Keyphrases
Colorectal Cancer
100%
Targeted Therapy
50%
Patient-derived Organoids
33%
Metabolic Reprogramming
33%
Anaplerotic
16%
Energy Substrates
16%
Organoid Biobank
16%
Metabolic Rewiring
16%
Epigenetic Vulnerability
16%
Metabolic Vulnerability
16%
Metabolic Landscape
16%
Acquired Resistance
16%
Colorectal Tumor
16%
Genetic Profile
16%
Supporting Cells
16%
Deregulation
16%
Unveiling
16%
Cancer Hallmarks
16%
Vulnerability
16%
Therapeutic Target
16%
Tumor Growth
16%
Cancer Study
16%
Patient Response
16%
Cellular Metabolism
16%
Reducing Equivalents
16%
Stress Conditions
16%
Oncogene
16%
Response to Therapy
16%
Tumor Initiation
16%
Genetic Basis
16%
Growth Conditions
16%
Direct Impact
16%
Clinical Approach
16%
Overcoming Resistance
16%
Proteomics
16%
Treatment Regimen
16%
Solid Tumors
16%
Cancer 2
16%
Cell Growth
16%
Tumor Survival
16%
Metabolic
16%
Tumor Resistance
16%
Metabolism
16%
Tumor Progression
16%
In Vitro Tumor Models
16%
Novel Therapeutics
16%
Colorectal Cancer Cells
16%
Epigenetics
16%
Adaptation
16%
Resistance to Therapy
16%
Biochemistry, Genetics and Molecular Biology
Reprogramming
100%
Metabolic Pathway
50%
Cell Growth
50%
Reducing Equivalent
50%
Medical Decision Making
50%
Genetics
50%
Epigenomics
50%
Epigenetics
50%
Cancer Cell
50%
Tumor Initiation
50%
Cell Metabolism
50%
Epigenetics
50%
Downregulation
50%
Precursor
50%
Tumor Progression
50%
Genomics
50%
Oncogene
50%
Proteomics
50%
Medicine and Dentistry
Colorectal Carcinoma
100%
Targeted Therapy
42%
Tumor Progression
28%
Organoid
28%
Proteomics
14%
Malignant Neoplasm
14%
Tumor Resistance
14%
Colorectal Tumor
14%
Cell Growth
14%
Cell Metabolism
14%
Downregulation
14%
Epigenomics
14%
Tumor Initiation
14%
Cancer Cell
14%
Solid Malignant Neoplasm
14%
Precursor
14%
Oncogene
14%
Medical Decision Making
14%